HSBC Holdings’s Antares Pharma, Inc. ATRS Stock Holding History

HSBC Holdings’s Portfolio ATRS Stock Details ATRS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	–	Sell	-20,551	Closed	-$85K	–	3546
2022 Q1	$85K	Buy	20,551 +101	+0.5%	+$366	﹤0.01%	3150
2021 Q4	$73K	Buy	20,450 +6,304	+45%	+$22K	﹤0.01%	3174
2021 Q3	$52K	Buy	+14,146	New	+$57.2K	﹤0.01%	2929
2021 Q1	–	Sell	-14,843	Closed	-$59K	–	3263
2020 Q4	$59K	Buy	+14,843	New	+$48K	﹤0.01%	2981
2020 Q1	–	Sell	-15,448	Closed	-$73K	–	3124
2019 Q4	$73K	Sell	15,448 -620	-4%	-$2.54K	﹤0.01%	2954
2019 Q3	$54K	Buy	+16,068	New	+$52.9K	﹤0.01%	3014

Other funds holding ATRS

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

HSBC Holdings's ATRS Position: Q2 2022 in Review

HSBC Holdings sold out of Antares Pharma, Inc. (ATRS) in Q2 2022, closing a stake of 20,551 shares — an estimated $85K sold.

HSBC Holdings first reported a position in ATRS in Q3 2019 and held it in 6 quarters. The position peaked at $85K in Q1 2022. 1 fund tracked by Wall St. Rank holds ATRS as of Q2 2022.

HSBC Holdings reported no remaining Antares Pharma, Inc. position as of Q2 2022 after selling out during the quarter.
HSBC Holdings sold 20,551 Antares Pharma, Inc. shares in Q2 2022, an estimated $85K.
HSBC Holdings first reported a position in Antares Pharma, Inc. in Q3 2019 and held it in 6 quarters.
HSBC Holdings's Antares Pharma, Inc. position peaked at $85K in Q1 2022.
1 fund tracked by Wall St. Rank held Antares Pharma, Inc. as of Q2 2022.

Based on HSBC Holdings's 13F filing for Q2 2022, filed 11 Aug 2022.